Long-term reversal of cholinergic neuronal decline in aged non-human primates by lentiviral NGF gene delivery.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Experimental Neurology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.expneurol.2008.10.004PMID 19013154PMCID PMC2632603
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Safety and tolerability of intraputaminal delivery of CERE-120 (adeno-associated virus serotype 2-neurturin) to patients with idiopathic Parkinson's disease: an open-label, phase I trial.

  2008cited by this paper
• Therapeutic potential of CERE-110 (AAV2-NGF): targeted, stable, and sustained NGF delivery and trophic activity on rodent basal forebrain cholinergic neurons.

  2008cited by this paper
• Efficient retrograde neuronal transduction utilizing self-complementary AAV1.

  2008cited by this paper
• An MRI study of age-related white and gray matter volume changes in the rhesus monkey.

  2008cited by this paper
• Transient Growth Factor Delivery Sustains Regenerated Axons after Spinal Cord Injury

  2007cited by this paper
• ERK-mediated NGF signaling in the rat septo-hippocampal pathway diminishes with age

  2006cited by this paper
• Regulated lentiviral NGF gene transfer controls rescue of medial septal cholinergic neurons.

  2005cited by this paper
• Altered Cellular Distribution of Phospho‐Tau Proteins Coincides with Impaired Retrograde Axonal Transport in Neurons of Aged Rats

  2005cited by this paper
• A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease

  2005cited by this paper
• Memory Impairment in Aged Primates Is Associated with Focal Death of Cortical Neurons and Atrophy of Subcortical Neurons

  2004cited by this paper
• Clinical trials in neurological disorders using AAV vectors: promises and challenges.

  2004cited by this paper
• Imaging correlates of brain function in monkeys and rats isolates a hippocampal subregion differentially vulnerable to aging.

  2004cited by this paper
• CENTRAL CHOLINERGIC PATHWAYS IN THE RAT : AN OVERVIEW BASED ON AN ALTERNATIVE NOMENCLATURE ( Chl-Ch 6 )

  2002cited by this paper
• Adeno-associated virus effectively mediates conditional gene modification in the brain

  2002cited by this paper
• Transgenesis by lentiviral vectors: Lack of gene silencing in mammalian embryonic stem cells and preimplantation embryos

  2002cited by this paper
• Nontropic actions of neurotrophins: subcortical nerve growth factor gene delivery reverses age-related degeneration of primate cortical cholinergic innervation.

  2001cited by this paper
• Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease.

  2000cited by this paper
• Neurite outgrowth can be modulated in vitro using a tetracycline‐repressible gene therapy vector expressing human nerve growth factor

  2000cited by this paper
• Gene transfer by lentiviral vectors is limited by nuclear translocation and rescued by HIV-1 pol sequences

  2000cited by this paper
• Conservation of neuron number and size in entorhinal cortex layers II, III, and V/VI of aged primates

  2000cited by this paper
• Age-associated neuronal atrophy occurs in the primate brain and is reversible by growth factor gene therapy.

  1999influential reference
• Leukemia Inhibitory Factor Augments Neurotrophin Expression and Corticospinal Axon Growth after Adult CNS Injury

  1999cited by this paper
• A Third-Generation Lentivirus Vector with a Conditional Packaging System

  1998cited by this paper
• Self-Inactivating Lentivirus Vector for Safe and Efficient In Vivo Gene Delivery

  1998cited by this paper
• The effects of aging on layer 1 in area 46 of prefrontal cortex in the rhesus monkey.

  1998cited by this paper
• Intracerebroventricular Infusion of Nerve Growth Factor in Three Patients with Alzheimer’s Disease

  1998cited by this paper
• Reversible schwann cell hyperplasia and sprouting of sensory and sympathetic neurites after intraventricular administration of nerve growth factor

  1997cited by this paper
• Preserved number of entorhinal cortex layer II neurons in aged macaque monkeys.

  1997cited by this paper
• Gene therapy in the adult primate brain: intraparenchymal grafts of cells genetically modified to produce nerve growth factor prevent cholinergic neuronal degeneration.

  1996cited by this paper
• Neurobiological Bases of Age-Related Cognitive Decline in the Rhesus Monkey

  1996cited by this paper
• Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector.

  1996cited by this paper
• Characterization of antibodies to nerve growth factor: assay-dependent variability in the cross-reactivity with other neurotrophins.

  1996cited by this paper
• Reduced retrograde labelling with fluorescent tracer accompanies neuronal atrophy of basal forebrain cholinergic neurons in aged rats.

  1996cited by this paper
• Distribution of radioiodinated recombinant human nerve growth factor in primate brain following intracerebroventricular infusion.

  1996cited by this paper
• Somatic gene transfer of NGF to the aged brain: behavioral and morphological amelioration

  1995cited by this paper
• Human nerve growth factor improves spatial memory in aged but not in young rats

  1994cited by this paper
• Implants of polymer‐encapsulated human NGF‐secreting cells in the nonhuman primate: Rescue and sprouting of degenerating cholinergic basal forebrain neurons

  1994cited by this paper
• The aged monkey basal forebrain: rescue and sprouting of axotomized basal forebrain neurons after grafts of encapsulated cells secreting human nerve growth factor.

  1994cited by this paper
• Cholinergic cell loss and hypertrophy in the medial septal nucleus of the behaviorally characterized aged rhesus monkey

  1992cited by this paper
• Distribution of nerve growth factor‐like immunoreactive neurons in the adult rat brain following colchicine treatment

  1992cited by this paper
• Hypophagia is induced by intracerebroventricular administration of nerve growth factor.

  1991cited by this paper
• Human nerve growth factor prevents degeneration of basal forebrain cholinergic neurons in primates

  1991cited by this paper
• Efficient selection for high-expression transfectants with a novel eukaryotic vector

  1991cited by this paper
• Efficient selection for high-expression transfectants with a novel eukaryotic vector.

  1991cited by this paper
• Recombinant human nerve growth factor infusions prevent cholinergic neuronal degeneration in the adult primate brain

  1991cited by this paper
• Nerve growth factor infusion in the primate brain reduces lesion- induced cholinergic neuronal degeneration

  1990cited by this paper
• Amelioration of cholinergic neuron atrophy and spatial memory impairment in aged rats by nerve growth factor

  1987cited by this paper
• Central cholinergic pathways in the rat: an overview based on an alternative nomenclature (Ch1-Ch6).

  1983cited by this paper
• Cholinergic innervation of cortex by the basal forebrain: Cytochemistry and cortical connections of the septal area, diagonal band nuclei, nucleus basalis (Substantia innominata), and hypothalamus in the rhesus monkey

  1983cited by this paper
• Age-related changes in prefrontal cortex of Macaca mulatta: quantitative analysis of dendritic branching patterns.

  1980cited by this paper

• Significance of gene therapy in neurodegenerative diseases

  2025cites this paper
• Viral vectors in neurodegenerative diseases: immune responses and therapeutic applications

  2025cites this paper
• Transduced Olfactory Mucosa Cells Expressing Nerve Growth Factor for the Therapy of Experimental Spinal Cord Cysts

  2024cites this paper
• The Use of Neurotrophic Factors as a Promising Strategy for the Treatment of Neurodegenerative Diseases (Review)

  2024cites this paper
• Advances and Challenges in Gene Therapy for Alzheimer’s Disease

  2024cites this paper
• Recent developments in translational imaging of in vivo gene therapy outcomes.

  2024cites this paper
• Degeneration of the cholinergic system in individuals with subjective cognitive decline: a systematic review.

  2024cites this paper
• Neurotrophic factors-based therapeutic strategies in the spinal cord injury: an overview of recent preclinical studies in rodent models

  2023cites this paper
• Title: The Effect of Aerobic Training With the Consumption of Probiotic on the Myelination of Nerve Fibers in Cuprizone-Induced Demyelination Mouse Model of Multiple Sclerosis

  2022cites this paper
• Neurotrophic factor-based pharmacological approaches in neurological disorders

  2022cites this paper
• Coadministration of tianeptine alters behavioral parameters and levels of neurotrophins in a chronic model of Maple Syrup Urine disease

  2022cites this paper
• The Effect of Aerobic Training With the Consumption of Probiotics on the Myelination of Nerve Fibers in Cuprizone-induced Demyelination Mouse Model of Multiple Sclerosis

  2022influential citation
• NGF Released from Blood Cells or Collagen Hydrogels as a Therapeutic Target in Alzheimer's Disease?

  2021cites this paper
• Nerve Growth Factor-Based Therapy in Alzheimer’s Disease and Age-Related Macular Degeneration

  2021cites this paper
• A Review of Techniques for Biodelivery of Nerve Growth Factor (NGF) to the Brain in Relation to Alzheimer's Disease.

  2021cites this paper
• Gene-based therapies for neurodegenerative diseases

  2021cites this paper
• Genetic Therapies for Alzheimer’s Disease: A Scoping Review

  2021cites this paper
• All roads lead to Rome — a review of the potential mechanisms by which exerkines exhibit neuroprotective effects in Alzheimer's disease

  2021cites this paper
• Neuromodulation for Cognitive Disorders: In Search of Lazarus?

  2020cites this paper
• Delivery of injectable thermo-sensitive hydrogel releasing nerve growth factor for spinal cord regeneration in rat animal model.

  2020cites this paper
• Postmortem Analysis in a Clinical Trial of AAV2-NGF Gene Therapy for Alzheimer's Disease Identifies a Need for Improved Vector Delivery

  2020cites this paper
• Innovative Therapy for Alzheimer’s Disease-With Focus on Biodelivery of NGF

  2019cites this paper
• Non-Invasive Brain Delivery and Efficacy of BDNF to Stimulate Neuroregeneration and Suppression of Disease Relapse in EAE Mice.

  2019cites this paper
• Aging with alcohol-related brain damage: Critical brain circuits associated with cognitive dysfunction.

  2019cites this paper
• THE IMPACT OF NEONATAL ALCOHOL EXPOSURE AND VOLUNTARY EXERCISE ON CHOLINERGIC FIBER LENGTH AND CG2 VOLUME IN THE RAT MEDIAL PREFRONTAL CORTEX

  2019cites this paper
• Multiply clustered gold-based nanoparticles complexed with exogenous pDNA achieve prolonged gene expression in stem cells

  2019cites this paper
• Modulation of the p75 neurotrophin receptor suppresses age-related basal forebrain cholinergic neuron degeneration

  2019cites this paper
• Brain organoids: a next step for humanized Alzheimer’s disease models?

  2019cites this paper
• Adolescent binge ethanol-induced loss of basal forebrain cholinergic neurons and neuroimmune activation are prevented by exercise and indomethacin

  2018cites this paper
• Targeting Alzheimer's disease with gene and cell therapies

  2018cites this paper
• Reduced NGF in Gastric Endothelial Cells Is One of the Main Causes of Impaired Angiogenesis in Aging Gastric Mucosa

  2018cites this paper
• Adeno-Associated Viral Vector (Serotype 2)–Nerve Growth Factor for Patients With Alzheimer Disease: A Randomized Clinical Trial

  2018cites this paper
• NGF steers microglia toward a neuroprotective phenotype

  2018cites this paper
• Nerve Growth Factor Is Responsible for Exercise-Induced Recovery of Septohippocampal Cholinergic Structure and Function

  2018cites this paper
• Role of nerve growth factor in plasticity of forebrain cholinergic neurons

  2017cites this paper
• Exercise leads to the re-emergence of the cholinergic/nestin neuronal phenotype within the medial septum/diagonal band and subsequent rescue of both hippocampal ACh efflux and spatial behavior.

  2016influential citation
• NGF and BDNF Gene Therapy for Alzheimer’s Disease

  2016cites this paper
• Dysfunctional Sensory Modalities, Locus Coeruleus, and Basal Forebrain: Early Determinants that Promote Neuropathogenesis of Cognitive and Memory Decline and Alzheimer’s Disease

  2016cites this paper
• Eph receptors: new players in Alzheimer's disease pathogenesis.

  2015cites this paper
• Intracerebroventricular administration of α-ketoisocaproic acid decreases brain-derived neurotrophic factor and nerve growth factor levels in brain of young rats

  2015cites this paper
• Contemporary Animal Models For Human Gene Therapy Applications.

  2015cites this paper
• Correction: Over-Expression of hNGF in Adult Human Olfactory Bulb Neural Stem Cells Promotes Cell Growth and Oligodendrocytic Differentiation

  2015cites this paper
• Lentiviral Mediated Overexpression of NGF in Adipose-derived Stem Cells

  2015cites this paper
• Expediting the Discovery and Potential Translation of Theranostic Agents for Alzheimer's Disease

  2015cites this paper
• Pharmacological treatment for Alzheimer’s disease

  2014cites this paper
• Effects of neural stem cells on synaptic proteins and memory in a mouse model of Alzheimer's disease

  2014cites this paper
• Novel targets for Alzheimer's disease treatment

  2014cites this paper
• Novel targets for Alzheimer's disease treatment

  2014cites this paper
• Cell Microencapsulation for Tissue Engineering and Regenerative Medicine

  2014cites this paper
• Alzheimer's disease: The role for neurosurgery

  2014cites this paper
• Human Mesenchymal Stem Cells Produce Bioactive Neurotrophic Factors: Source, Individual Variability and Differentiation Issues

  2014cites this paper
• MiR-126 Regulates Growth Factor Activities and Vulnerability to Toxic Insult in Neurons

  2014cites this paper
• Neural Stem Cell Transplants Improve Cognitive Function Without Altering Amyloid Pathology in an APP/PS1 Double Transgenic Model of Alzheimer’s Disease

  2014cites this paper
• Stimulate or degenerate: deep brain stimulation of the nucleus basalis Meynert in Alzheimer dementia.

  2013cites this paper
• BAFF Controls Neural Cell Survival through BAFF Receptor

  2013cites this paper
• Over-Expression of hNGF in Adult Human Olfactory Bulb Neural Stem Cells Promotes Cell Growth and Oligodendrocytic Differentiation

  2013cites this paper
• Brain Delivery of NAP with PEG-PLGA Nanoparticles Modified with Phage Display Peptides

  2013cites this paper
• The entorhinal cortex and neurotrophin signaling in Alzheimer’s disease and other disorders

  2013cites this paper
• Toward the treatment and prevention of Alzheimer's disease: rational strategies and recent progress.

  2013cites this paper
• Longitudinal measures of cholinergic forebrain atrophy in the transition from healthy aging to Alzheimer's disease.

  2013cites this paper
• Nerve growth factor retrieves neuropeptide Y and cholinergic immunoreactivity in the nucleus accumbens of old rats.

  2013cites this paper
• Atrophy of the cholinergic Basal forebrain over the adult age range and in early stages of Alzheimer's disease.

  2012cites this paper
• Novel gene therapeutic approaches to prolong corneal allograft survival

  2012cites this paper
• New pharmacological strategies for treatment of Alzheimer's disease: focus on disease modifying drugs.

  2012cites this paper
• Targeted delivery of nerve growth factor via encapsulated cell biodelivery in Alzheimer disease: a technology platform for restorative neurosurgery.

  2012cites this paper
• Encapsulated Cell Biodelivery of Nerve Growth Factor to the Basal Forebrain in Patients with Alzheimer’s Disease

  2012cites this paper
• EPIGENETIC MECHANISMS IN ALZHEIMER'S DISEASE: STATE-OF-THE-ART

  2012cites this paper
• CXB-909 Attenuates Cognitive Deficits in the Mu-P-75 Saporin Mouse Model of Alzheimer’s Disease

  2012cites this paper
• Brain-derived neurotrophic factor: the link between amyloid-β and memory loss

  2011cites this paper
• The role of tumor necrosis factor receptor superfamily members in mammalian brain development, function and homeostasis

  2011cites this paper
• Disrupted energy metabolism and neuronal circuit dysfunction in cognitive impairment and Alzheimer's disease.

  2011cites this paper
• Updates on current advances in gene therapy.

  2011cites this paper
• Cerebrolysin in Alzheimer's disease.

  2011cites this paper
• The cholinergic system in aging and neuronal degeneration.

  2011cites this paper
• eview he cholinergic system in aging and neuronal degeneration

  2010cites this paper
• Lack of Humoral Immune Response to the Tetracycline (Tet) Activator in Rats Injected Intracranially with Tet-off rAAV Vectors

  2010cites this paper
• Differential effects of short‐ and long‐term hyperhomocysteinaemia on cholinergic neurons, spatial memory and microbleedings in vivo in rats

  2010cites this paper
• Tryptamine-derived alkaloids from Annonaceae exerting neurotrophin-like properties on primary dopaminergic neurons.

  2010cites this paper
• Computational Prediction and Analysis of the NAPP – DR6 Interaction: Implications for Alzheimer's Research

  2010cites this paper
• Learning induces neurotrophin signaling at hippocampal synapses

  2010cites this paper
• Viral vector-mediated gene transfer for CNS disease

  2010cites this paper
• CERE-110, an adeno-associated virus-based gene delivery vector expressing human nerve growth factor for the treatment of Alzheimer's disease.

  2010cites this paper
• Current therapeutic targets for the treatment of Alzheimer’s disease

  2010cites this paper
• Viral vectors for neurotrophic factor delivery: a gene therapy approach for neurodegenerative diseases of the CNS.

  2010cites this paper
• Moderate developmental undernutrition: Impact on growth and cognitive function in youth and old age.

  2010cites this paper
• Pharmacological treatment for Alzheimer's disease: current approaches and future strategies.

  2010cites this paper
• Large animal models of neurological disorders for gene therapy.

  2009cites this paper
• Chapter 20: Gene therapy perspectives for nerve repair.

  2009cites this paper